My estimates based on the number of patients and their year of enrollment and % overall survival at different time points, has the events being completed in 2019-2020. I highly doubt all events will happen in 2018.
It really would have made sense for them to do some sort of interim analysis. At least to show a signal of Multikine effectiveness.
Replace “hope” in your factual statement with a more appropriate word. Then review and revise your “optimistic” opinion. Geert said “optimistic”....and a lot of other things ....and the share structure says otherwise.
Tiring of rudimentary verbiage. I’m guilty. Will work to clean it up. Hope doesn’t displace reality....not even at 1000 to 1.....at 1m to 1 maybe. So...feel free to buy 1 share $2 at a commission of $10; and hope!
I had done the math on this about a month ago and came to the conclusion based on how many enrolled by end of which years that indeed end of 2018 early 2019. Very not likely before end of 2018